This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of California. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Max Horlbeck: Innovator in CRISPR Technology
Introduction
Max Horlbeck is a prominent inventor based in Oakland, CA (US). He has made significant contributions to the field of genetic engineering, particularly through his work on CRISPR technology. His innovative approach has led to advancements in transcriptional modulation, which has important implications for research and therapeutic applications.
Latest Patents
Max Horlbeck holds a patent for "CRISPR/Cas transcriptional modulation." This patent encompasses methods, compositions, and kits that facilitate CRISPR/Cas mediated transcriptional modulation. His work in this area is groundbreaking and showcases the potential of CRISPR technology in various scientific fields.
Career Highlights
Max is affiliated with the University of California, where he continues to push the boundaries of genetic research. His dedication to innovation and excellence in his field has earned him recognition among his peers and the scientific community.
Collaborations
Max has collaborated with notable researchers, including Lei S Qi and Luke A Gilbert. These partnerships have further enhanced the impact of his work and contributed to the advancement of CRISPR technology.
Conclusion
Max Horlbeck is a key figure in the realm of genetic engineering, with a focus on CRISPR technology. His contributions are shaping the future of genetic research and therapy.